This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Johns Hopkins University. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Yolanda Fortenberry: Innovator in Sickle Cell Disease Treatment
Introduction
Yolanda Fortenberry is a distinguished inventor based in Pikesville, MD (US). She has made significant contributions to the field of medical research, particularly in the treatment of sickle cell disease. With a total of 2 patents to her name, her work is paving the way for innovative therapeutic solutions.
Latest Patents
Among her latest patents is a groundbreaking invention involving polynucleotide aptamers for the treatment of sickle cell disease. This invention provides aptamers that selectively bind to and inhibit the polymerization of sickle hemoglobin (HbS). The patent also includes pharmaceutical compositions comprising these aptamers, methods of use for diagnostics and treatment of sickle cell disease, and methods of rational drug design.
Career Highlights
Yolanda Fortenberry is affiliated with Johns Hopkins University, where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
She has collaborated with notable colleagues, including James Francis Casella and Emily Barron-Casella, to further her research initiatives.
Conclusion
Yolanda Fortenberry's innovative work in the treatment of sickle cell disease exemplifies her dedication to medical research and her impact on the field. Her contributions are vital in the ongoing quest for effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile